T. Valyi-Nagy

Therapy of experimental human brain tumors using a neuroattenuated herpes simplex virus mutant.

Santosh Kesari, B. Randazzo, T. Valyi-Nagy et al. · PubMed · 1995 · 123 citations

Medicine, Neuroscience, Oncology +11

Herpes simplex virus type 1 latency-associated transcript (LAT) promoter deletion mutants can express a 2-kilobase transcript mapping to the LAT region

M Nicosia, Satish L. Deshmane, Janice M. Zabolotny et al. · Journal of Virology · 1993 · 45 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

Replication, establishment of latent infection, expression of the latency-associated transcripts and explant reactivation of herpes simplex virus type 1  34.5 mutants in a mouse eye model

J G Spivack, Moin U. Fareed, T. Valyi-Nagy et al. · Journal of General Virology · 1995 · 37 citations

Life Sciences, Infectious Diseases, Molecular Biology +17

Oral inoculation of SCID mice with an attenuated herpes simplex virus-1 strain causes persistent enteric nervous system infection and gastric ulcers without direct mucosal infection.

Gesser Rm, T. Valyi-Nagy, Fraser Nw et al. · PubMed · 1995 · 21 citations

Veterinary Medicine, Infectious Diseases, Pathobiology +14

An HSV-1 containing the rat beta-glucuronidase cDNA inserted within the LAT gene is less efficient than the parental strain at establishing a transcriptionally active state during latency in neurons.

Deshmane Sl, T. Valyi-Nagy, Timothy M. Block et al. · PubMed · 1995 · 18 citations

Life Sciences, Molecular Biology, Molecular Genetics +10